Sarepta Therapeutics, Inc. SRPT Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — revenue?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — revenue of $730.8M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — revenue changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — revenue decreased by 1.9% year-over-year, from $744.86M to $730.8M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — revenue?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — revenue has grown at a 33.1% compound annual growth rate (CAGR), from $933.01M to $2.2B.
- What does business segments — revenue mean?
- Represents the total gross income generated by the business segment from the sale of goods or services. This metric serves as a primary indicator of the segment's market demand and top-line growth performance.